Oppenheimer Initiates Coverage on Eurand (EURX)
More News related to EURX
- Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Bank of America Initiates Coverage on Eurand N.V. (EURX) with a Neutral
- Eurand to Participate in Upcoming Investor Conferences
- Eurand Completes Public Offering, Including Exercise of the Underwriters' Over-Allotment Option, for Total Net Proceeds of Approximately $103.9 Million
Oppenheimer initiates coverage on Eurand (Nasdaq: EURX) with an Outperform. Price target $16.
To see more analyst ratings on EURX Click Here.
Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company.
Related Categories
New CoverageStocks Mentioned
+0.21Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
